Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
Yoshihiro Kawaoka, Ryuta Uraki, Maki Kiso, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein
Thomas P. Peacock, Jonathan C. Brown, Jie Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 255
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains
James Brett Case, Samantha Mackin, John M. Errico, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 134
Impact of African-Specific ACE2 Polymorphisms on Omicron BA.4/5 RBD Binding and Allosteric Communication Within the ACE2–RBD Protein Complex
Victor Barozi, Özlem Taştan Bishop
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1367-1367
Open Access | Times Cited: 2
Protective neutralizing epitopes in SARS‐CoV‐2
Hejun Liu, Ian A. Wilson
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 76-92
Open Access | Times Cited: 40
Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2
Jasper Fuk‐Woo Chan, Bingjie Hu, Yue Chai, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 9, pp. 100743-100743
Open Access | Times Cited: 40
Omicron variant evolution on vaccines and monoclonal antibodies
Michela Sabbatucci, Antonio Vitiello, Salvatore Clemente, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1779-1788
Open Access | Times Cited: 25
SARS-CoV-2 Variants Show a Gradual Declining Pathogenicity and Pro-Inflammatory Cytokine Stimulation, an Increasing Antigenic and Anti-Inflammatory Cytokine Induction, and Rising Structural Protein Instability: A Minimal Number Genome-Based Approach
Debmalya Barh, Sandeep Tiwari, Lucas Gabriel Rodrigues Gomes, et al.
Inflammation (2022) Vol. 46, Iss. 1, pp. 297-312
Open Access | Times Cited: 31
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains
James Brett Case, Samantha Mackin, John M. Errico, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 29
Reduced Pathogenicity and Transmission Potential of Omicron BA.1 and BA.2 Sublineages Compared with the Early Severe Acute Respiratory Syndrome Coronavirus 2 D614G Variant in Syrian Hamsters
Wen Su, Ka Tim Choy, Haogao Gu, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 10, pp. 1143-1152
Open Access | Times Cited: 26
The efficacy of paxlovid in elderly patients infected with SARS-CoV-2 omicron variants: Results of a non-randomized clinical trial
Weijie Zhong, Jiang Xiu-feng, Xiaosheng Yang, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 23
Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review
Nour Shaheen, Abdelrahman Mohamed, Almoatazbellah Attalla, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 6317-6330
Open Access | Times Cited: 14
Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain
Baoling Ying, Chieh-Yu Liang, Pritesh Desai, et al.
Journal of Virology (2024) Vol. 98, Iss. 9
Open Access | Times Cited: 2
Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients
Florentino Villanego, Auxiliadora Mazuecos, Beatriz Rodríguez Cubillo, et al.
Clinical Kidney Journal (2022) Vol. 15, Iss. 10, pp. 1847-1855
Open Access | Times Cited: 10
As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?
Ren Xu, Wanning Wang, Wenlong Zhang
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 10
Redistribution and Activation of CD16brightCD56dim NK Cell Subset to Fight against Omicron Subvariant BA.2 after COVID-19 Vaccination
Huiyun Peng, Tianxin Xiang, Fei Xu, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 940-940
Open Access | Times Cited: 5
Evolutionary progression of collective mutations in Omicron sub-lineages towards efficient RBD-hACE2: Allosteric communications between and within viral and human proteins
Victor Barozi, Adrienne L. Edkins, Özlem Taştan Bishop
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 4562-4578
Open Access | Times Cited: 6
Differences Between Omicron Infections and Fever Outpatients: Comparison of Clinical Manifestations and Initial Routine Hematology Indicators
Xiaojie Bi, Ying Zhang, Juan Pan, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 5111-5120
Open Access | Times Cited: 4
Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain
Baoling Ying, Chieh-Yu Liang, Pritesh Desai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
SARS-CoV-2 delta (B.1.617.2) spike protein adjuvanted with Alum-3M-052 enhances antibody production and neutralization ability
Hong Huang, Zhongcheng Zhou, Xinxin Xiong, et al.
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 1
A retrospective analysis of factors associated with the length of hospital stay in COVID-19 patients treated with Nirmatrelvir / Ritonavir
Jiantao Zheng, Wencong Hong, Chanjuan Zhou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 1
Immune escape of SARS-CoV-2 variants to therapeutic monoclonal antibodies: a system review and meta-analysis
Huichun Shi, Jiajia Sun, Yigang Zeng, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Risk of extended viral shedding of Omicron BA.2 in Shanghai: Implications for vaccination strategy optimization
Jingwen Huang, Lin Huang, Jing Xi, et al.
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2023) Vol. 1, Iss. 4, pp. 241-248
Open Access | Times Cited: 1
Time-series comparison of COVID-19 case fatality rates across 21 countries with adjustment for multiple covariates
Yongmoon Kim, Bryan Kim, Sangwoo Tak
Osong Public Health and Research Perspectives (2022) Vol. 13, Iss. 6, pp. 424-434
Open Access | Times Cited: 2
Redistribution and activation of CD16brightCD56dimNK cell subset to fight against Omicron subvariant BA.2 after COVID-19 vaccination
Yang Liu, Huiyun Peng, Tianxin Xiang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Denisa Bojková, Richard S. Stack, Tamara Rothenburger, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1 - Next Page

Scroll to top